Eastern Asia: Market for Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives 2024

Market Size for Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives in Eastern Asia

The East Asian market for medicaments of antibiotics other than penicillins, streptomycins or their derivatives contracted to $X in 2023, dropping by X% against the previous year. Overall, consumption, however, recorded a relatively flat trend pattern. As a result, consumption reached the peak level of $X. From 2021 to 2023, the growth of the market remained at a somewhat lower figure.

Production of Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives in Eastern Asia

In value terms, non-penicillin or streptomycin antibiotic medicaments production contracted modestly to $X in 2023 estimated in export price. The total production indicated a modest expansion from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, production decreased by X% against 2020 indices. The pace of growth appeared the most rapid in 2020 when the production volume increased by X% against the previous year. As a result, production reached the peak level of $X. From 2021 to 2023, production growth remained at a somewhat lower figure.

Exports of Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives

Exports in Eastern Asia

Non-penicillin or streptomycin antibiotic medicaments exports expanded significantly to X tons in 2023, picking up by X% against 2022 figures. Total exports indicated a strong increase from 2012 to 2023: its volume increased at an average annual rate of X% over the last eleven-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth was the most pronounced in 2015 when exports increased by X%. Over the period under review, the exports reached the maximum in 2023 and are likely to continue growth in years to come.

In value terms, non-penicillin or streptomycin antibiotic medicaments exports totaled $X in 2023. Total exports indicated measured growth from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, exports increased by X% against 2014 indices. The most prominent rate of growth was recorded in 2020 with an increase of X%. Over the period under review, the exports attained the peak figure in 2023 and are expected to retain growth in years to come.

Exports by Country

China prevails in exports structure, accounting for X tons, which was near X% of total exports in 2023. South Korea (X tons) followed a long way behind the leaders.

China was also the fastest-growing in terms of the medicaments of antibiotics other than penicillins, streptomycins or their derivatives exports, with a CAGR of X% from 2012 to 2023. South Korea experienced a relatively flat trend pattern. From 2012 to 2023, the share of China increased by X percentage points.

In value terms, China ($X) remains the largest non-penicillin or streptomycin antibiotic medicaments supplier in Eastern Asia, comprising X% of total exports. The second position in the ranking was taken by South Korea ($X), with an X% share of total exports.

In China, non-penicillin or streptomycin antibiotic medicaments exports expanded at an average annual rate of X% over the period from 2012-2023.

Export Prices by Country

The export price in Eastern Asia stood at $X per ton in 2023, which is down by X% against the previous year. Over the period under review, the export price showed a noticeable downturn. The most prominent rate of growth was recorded in 2020 an increase of X% against the previous year. The level of export peaked at $X per ton in 2012; however, from 2013 to 2023, the export prices stood at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was South Korea ($X per ton), while China totaled $X per ton.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by China (X%).

Imports of Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives

Imports in Eastern Asia

Non-penicillin or streptomycin antibiotic medicaments imports declined to X tons in 2023, reducing by X% compared with the year before. Overall, imports, however, showed a relatively flat trend pattern. The pace of growth appeared the most rapid in 2017 when imports increased by X%. The volume of import peaked at X tons in 2019; however, from 2020 to 2023, imports remained at a lower figure.

In value terms, non-penicillin or streptomycin antibiotic medicaments imports contracted to $X in 2023. The total import value increased at an average annual rate of X% from 2012 to 2023; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth appeared the most rapid in 2017 with an increase of X% against the previous year. Over the period under review, imports hit record highs at $X in 2018; however, from 2019 to 2023, imports stood at a somewhat lower figure.

Imports by Country

China was the largest importing country with an import of around X tons, which finished at X% of total imports. Japan (X tons) held a X% share (based on physical terms) of total imports, which put it in second place, followed by Taiwan (Chinese) (X%) and South Korea (X%). The following importers - Democratic People's Republic of Korea (X tons) and Hong Kong SAR (X tons) - each resulted at a X% share of total imports.

From 2012 to 2023, average annual rates of growth with regard to non-penicillin or streptomycin antibiotic medicaments imports into China stood at X%. At the same time, Taiwan (Chinese) (X%), Democratic People's Republic of Korea (X%), South Korea (X%) and Hong Kong SAR (X%) displayed positive paces of growth. Moreover, Taiwan (Chinese) emerged as the fastest-growing importer imported in Eastern Asia, with a CAGR of X% from 2012-2023. Japan experienced a relatively flat trend pattern. From 2012 to 2023, the share of Taiwan (Chinese) and South Korea increased by X and X percentage points, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, China ($X) constitutes the largest market for imported medicaments of antibiotics other than penicillins, streptomycins or their derivatives in Eastern Asia, comprising X% of total imports. The second position in the ranking was taken by Hong Kong SAR ($X), with a X% share of total imports. It was followed by Japan, with a X% share.

In China, non-penicillin or streptomycin antibiotic medicaments imports increased at an average annual rate of X% over the period from 2012-2023. In the other countries, the average annual rates were as follows: Hong Kong SAR (X% per year) and Japan (X% per year).

Import Prices by Country

In 2023, the import price in Eastern Asia amounted to $X per ton, with an increase of X% against the previous year. Over the last eleven years, it increased at an average annual rate of X%. The growth pace was the most rapid in 2021 when the import price increased by X% against the previous year. As a result, import price reached the peak level of $X per ton. From 2022 to 2023, the import prices failed to regain momentum.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Hong Kong SAR ($X,674 per ton), while Democratic People's Republic of Korea ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by China (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform